Vaccine diplomacy

Last updated
Arrival of Salk Polio Vaccine from the United States at Amsterdam Airport Schiphol in 1957. Eerste salk-vaccin voor polio arriveert op Schiphol. Van links naar rechts W. va, Bestanddeelnr 908-9050.jpg
Arrival of Salk Polio Vaccine from the United States at Amsterdam Airport Schiphol in 1957.

Vaccine diplomacy, [1] a form of medical diplomacy, is the use of vaccines to improve a country's diplomatic relationship and influence of other countries. [2] [3] Meanwhile, vaccine diplomacy also "means a set of diplomatic measures taken to ensure access to the best practices in the development of potential vaccines, to enhance bilateral and/or multilateral cooperation between countries in conducting joint R&D, and, in the case of the announcement of production, to ensure the signing of a contract for the purchase of the vaccine at the shortest term." [4] Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part in the distribution of the smallpox vaccine. [5] [6] [7]

Contents

Early history of vaccine diplomacy

Commentators have identified vaccine diplomacy occurring as far back as the first vaccine, Edward Jenner's smallpox vaccine. [8] It has also been identified in Soviet involvement with the Albert Sabin polio vaccine. The UN has also brokered ceasefires in order to conduct vaccination campaigns such as with talibans in Afghanistan. [9]

During the COVID-19 pandemic

Australia

Australia promised to ensure early access to a vaccine "for countries in our Pacific family, as well as regional partners in Southeast Asia". [10] to help them fight the COVID-19 pandemic.

China

China's infection rates and early success in handling the COVID-19 pandemic were sufficiently low that it could send vaccines abroad without domestic objections. [11] By August 2021, China had donated 700 million vaccine does abroad, greater than the number from all other countries combined. [12] : 199  As academic Suisheng Zhao writes, "Just by showing up and helping plug the colossal gaps in the global supply, China gained ground." [11] Moreover, the Center for Strategic and International Studies found that its vaccine diplomatic activities earned China goodwill and influence in several middle-income countries, many of which are also notably involved in the Belt and Road Initiative, indicating that such diplomacy could have improved China's image and strengthened its relationships with countries that wished for, or already took part in, strong relationships with China. [13] However, because most of Chinese distributed vaccines have gone to such middle-income countries, many of the poorest countries are left highly vulnerable, undercutting China's attempts to present itself as a benevolent giver of needed goods and undermining Xi's claim that a Chinese developed vaccine would be treated as a “global public good." [14]

The Sinopharm BIBP vaccine is used for vaccinations by some countries in Asia, [15] [16] [17] Africa, [18] [19] [20] South America, [21] [22] [23] and Europe. [24] [25] [26] Sinopharm produced one billion doses of the BBIB vaccine in 2021, [27] and supplied 200 million doses by May. [28]

CoronaVac is used for vaccinations by some countries in Asia, [29] [30] [31] South America, [32] [33] [34] North America, [35] [36] [37] and Europe. [38] [39] [40] Sinovac had a production capacity of 2 billion doses a year [41] and had delivered 600 million total doses. [42]

Convidecia is used for vaccination by some countries in Asia, [43] [44] [45] Europe, [46] [47] and Latin America. [48] [49] [50] Production capacity for Ad5-NCov should reach 500 million doses in 2021. [51]

China pledged US$2 billion to support efforts by WHO for programs against COVID-19, a US$1 billion loan to make its vaccine accessible for countries in Latin America and the Caribbean, and provide five Southeast Asian countries priority access to the vaccine. [52] [53] [54] The Sinopharm BIBP vaccine and CoronaVac were approved by the WHO as part of COVAX. [42] [55] By July 2021, GAVI had signed advanced purchase agreements for 170 million doses of the Sinopharm BIBP vaccine, 350 million doses of CoronaVac, and 414 million doses of SCB-2019, another COVID-19 vaccine in Phase III trials. [56] [57]

All of these actions have been a component in enacting China's strategy of enacting mask diplomacy, where the state has distributed medical supplies, including COVID-19 vaccines, and financial support to other European countries, in an effort to restore China's historically maligned and recently ignominious image. While on the other hand, these actions have demonstrated that China is a pragmatic, self-driven problem solver, willing to establish alliances with other nations contrasting the United States' isolationist policies. [58]

In addition, China is utilizing this opportunity to distance, and even shift the narrative regarding the start of COVID-19, as the virus was discovered in the nation. [59] Although China gained some international sympathy, the country was also accosted by “accusations of fanning the pandemic by silencing early reports” and “dogged by international criticisms that trace the origins of the pandemic to a leak from a Wuhan lab.” [60] A 2020 Pew Research poll further suggests a negative narrative surround China; upon polling citizens in 14 economically advanced nations, including East Asian neighbors Japan and South Korea, a median of 61% said China did "a bad job dealing with the [COVID-19] outbreak" and 78% said they had no confidence in President Xi. [61] Such a poor global perception could suggest that China's distributed vaccines as a means of repairing or strengthening the country's international image. Providing vaccination doses allowed China to combat negative narratives about its early handling of the crisis and recast itself as a provider of needed goods, while cultivating goodwill and showcasing the nation’s technological strength. Through distributing their vaccines, China clearly took a stride to appear favorable in the eyes of the world, and perhaps reverse the criticism garnered at the early stages of the pandemic.

India

India sent COVID-19 vaccine to Seychelles under the Vaccine Maitri Program. COVID-19 vaccine from India to Seychelles.jpg
India sent COVID-19 vaccine to Seychelles under the Vaccine Maitri Program.

By late March 2021, India had produced 125 million doses of COVID-19 vaccines and had exported 55 million doses. [62] 84 countries had received vaccines from India, either through COVAX, grants or regular purchases. [63]

India sent millions of doses of COVID-19 vaccine to 95 countries including neighboring Bhutan, Afghanistan, Nepal, Bangladesh, Sri Lanka, Myanmar and the Maldives. [64] India will also supply vaccines to Pakistan through COVAX initiative. [65]

During the second wave of the COVID-19 pandemic in India, the Vaccine Maitri program was put on hold until July 2021 due to increased number of COVID cases in India. [66] [67] As of 29 May 2021, India had exported 66.4 million doses including 10.7 million vaccine provided as grant to more than 95 nations. [68]

India's health ministry said the country will resume COVID-19 vaccine exports as a part of COVAX and Vaccine Maitri initiative, by October, promising supply development that comes ahead of high-level talks this week on solving vaccine inequity gaps, while World Health Organization chief Tedros Adhanom Ghebreyesus has hailed India's decision to resume COVID-19 vaccine exports as an "important development" in support of the goal to reach 40 per cent vaccination in all countries by end of the year. [69]

Mexico

Secretary of Foreign Affairs of Mexico Marcelo Ebrard announced agreements with CanSino Biologics and Walvax to conduct clinical trials for vaccines from China, with the possibility of the manufacturing the vaccines in the country. [70]

Marcelo Ebrard also announced agreements with Johnson & Johnson to trial its U.S. developed vaccine in Mexico. [70]

Japan

In July 2020, Japan agreed to provide 11.6 billion yen (US$109 million) to five countries along the Mekong River: Cambodia, Laos, Myanmar, Thailand and Vietnam over concerns with China's influence on vaccine production and distribution in Asia. [71]

Russia

Russia, the first country to claim a COVID-19 vaccine, [72] Sputnik V, says twenty countries "including Brazil, Indonesia and the United Arab Emirates" have requested access. [3]

Turkey

Turkey has sent or donated CoronaVac vaccines to Azerbaijan, Bosnia and Herzegovina, Northern Cyprus, and North Macedonia. [73] [74]

United States

During the Trump administration, Secretary of Health and Human Services Alex Azar said the United States will share a vaccine with other countries only after the United States' needs have been met. [3] The United States has funded [75] and placed multi-billion dollar orders purchasing hundreds of millions of vaccines from the United Kingdom's AstraZeneca and Germany's BioNTech SE in collaboration with American Pfizer. [76] The United States offered vaccine development to Indonesia in an August 2020 phone call between Mike Pompeo and Retno Marsudi. [71]

President Biden in the Quad summit (with Japan, India, Australia Leaders) P20210312AS-0321 (51102889140).jpg
President Biden in the Quad summit (with Japan, India, Australia Leaders)

The Biden administration has promised to finance vaccine manufacturing in various nations with its announcement in the Quad Summit held in March 2021 that it will provide supply of up to one billion coronavirus vaccines across Asia by the end of 2022 along with India, Australia and Japan. [77] The United States vaccine export policies have been criticised as "Vaccine Apartheid" by The Independent . [78]

European Union

UK-based AstraZeneca was accused of prioritizing the UK market and when their EU vaccine production lagged behind the UK. Diplomatic protests from the Irish and UK sides resolved the matter and the threat was withdrawn. [79] In March 2021, the EU planned to suspend vaccine exports once again in order to incentivize the UK to export its domestic vaccine production. [80]

Vaccine nationalism

This led to fears about vaccine nationalism, [81] where developed countries would benefit in producing home-grown vaccine and poorer countries would not get access to the vaccine as soon, ultimately prolonging the pandemic. [82] A similar phenomenon was observed during the H1N1 Flu and Ebola crisis. [83] During the pandemic situation, there is a "diplomatic race ... for potential vaccines."[ according to whom? ] [4]

Another concern has been that wealthier countries would gain prioritized access to vaccines based on their ability to pay. [84] The COVAX program was established with the intention of counteracting this development. [85] In 2021, an unequal distribution of vaccines based on the principle of vaccine nationalism was observed between high, middle, and low income countries. An August 2021 study concluded that this behavior has resulted in increased transmission of COVID-19, especially because it encourages the development of COVID-19 variants. [86]

Possible collaboration among countries

In early August 2020, Malaysian Minister of Foreign Affairs Hishammuddin Hussein said on Twitter that he had spoken with both Chinese Foreign Minister Wang Yi and United States Secretary of State Mike Pompeo on methods to further collaboration on vaccines. [87] [88] [3]

See also

Further reading

Related Research Articles

<span class="mw-page-title-main">Sinovac Biotech</span> Chinese biopharmaceutical company

Sinovac Biotech Ltd. is a Chinese biopharmaceutical company based in Haidian District, Beijing that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight. The company has faced bribery probes in China.

<span class="mw-page-title-main">Sinopharm (company)</span> Chinese state-owned enterprise

China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine, Shanghai Shyndec Pharmaceutical, and Beijing Tiantan Biological Products.

<span class="mw-page-title-main">CoronaVac</span> Vaccine against COVID-19

CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. It was phase III clinically trialled in Brazil, Chile, Indonesia, the Philippines, and Turkey and relies on traditional technology similar to other inactivated-virus COVID-19 vaccines, such as the Sinopharm BIBP vaccine, another Chinese vaccine, and Covaxin, an Indian vaccine. CoronaVac does not need to be frozen, and both the final product and the raw material for formulating CoronaVac can be transported refrigerated at 2–8 °C (36–46 °F), the temperatures at which flu vaccines are kept.

<span class="mw-page-title-main">COVAX</span> Initiative to provide COVID-19 vaccines

COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO), alongside key delivery partner UNICEF. It is one of the four pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the WHO, the European Commission, and the government of France as a response to the COVID-19 pandemic. COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines. UNICEF is the key delivery partner, leveraging its experience as the largest single vaccine buyer in the world and working on the procurement of COVID-19 vaccine doses, as well as logistics, country readiness and in-country delivery.

<span class="mw-page-title-main">Sinopharm BIBP COVID-19 vaccine</span> Vaccine against COVID-19

The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine, not to be confused with the similar product name of CoronaVac.

The COVID-19 vaccination program in the Philippines was a mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a day after the arrival of the country's first vaccine doses which were donated by the Chinese government.

<span class="mw-page-title-main">COVID-19 vaccination in Albania</span>

The COVID-19 vaccination campaign in Albania is a mass immunization campaign that was put in place by the Albanian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 11 January 2021.

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">COVID-19 vaccination in Africa</span> Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs are ongoing in the majority countries and territories in Africa, with 51 of 54 African countries having launched vaccination programs by July 2021. As of October 2023, 51.8% of the continent's population is fully vaccinated with over 1084.5 million doses administered.

<span class="mw-page-title-main">COVID-19 vaccination in Vietnam</span> Plan to immunize against COVID-19 in Vietnam

The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. The Sinopharm BIBP vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021, and Covaxin from Bharat Biotech on 10 November 2021.

<span class="mw-page-title-main">COVID-19 vaccination in Indonesia</span> Plan to immunize against COVID-19

The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. In terms of total doses given, Indonesia ranks third in Asia and fifth in the world.

<span class="mw-page-title-main">COVID-19 vaccination in Bangladesh</span> Immunisation programme against COVID-19 in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

<span class="mw-page-title-main">COVID-19 vaccination in Singapore</span> Plan to immunize against COVID-19

The COVID-19 vaccination in Singapore is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Singapore has a very high vaccination rate, with more than 92% of its total population having completed their vaccination regimen.

<span class="mw-page-title-main">COVID-19 vaccination in Nepal</span> Immunisation programme against COVID-19 in Nepal

Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal brought 2 million doses from Serum Institute of India (SII) and was one of the first to receive COVID-19 vaccines. The delivery of the first 1 million doses arrived on 21 February. In March, India's decision to ban exports of vaccines created uncertainty over whether Nepal would be able to continue its vaccinations. By April, SII had only provided half of the 2 million doses for which Nepal had paid in full. A spokesperson for the Indian Ministry of External Affairs rejected the notion of an export ban and said "We will export vaccines taking into account the domestic demand." By late July, there was still uncertainty in Nepal over when SII would deliver the vaccines that were purchased, although Prime Minister Narendra Modi said India would "resume the supply of vaccines soon."

<span class="mw-page-title-main">COVID-19 vaccination in Sri Lanka</span> Plan to immunize against COVID-19

COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.

COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">COVID-19 vaccination in mainland China</span> Plan to immunize against COVID-19


COVID-19 vaccination in mainland China is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in mainland China, in response to the ongoing pandemic in the region.

References

  1. ↑ Srinivas, Krishna Ravi (11 March 2021). "Understanding Vaccine Diplomacy for the Anthropocene, Anti-Science Age". The Wire Science. Retrieved 11 March 2021.
  2. ↑ Snyder, Alison (20 August 2020). "A coronavirus vaccine is a chance for China to show its scientific muscle". Axios. Retrieved 21 August 2020.
  3. 1 2 3 4 Deng, Chao (17 August 2020). "China Seeks to Use Access to Covid-19 Vaccines for Diplomacy". Wall Street Journal. ISSN   0099-9660 . Retrieved 21 August 2020.
  4. 1 2 Abduazimov, Muzaffar S. (2021). "Inside Diplomacy during the Pandemic: Change in the Means and Ways of Practice". Indonesian Quarterly. SSRN   3854295.
  5. ↑ Blume, Stuart (19 March 2020). McInnes, Colin; Lee, Kelley; Youde, Jeremy (eds.). "The Politics of Global Vaccination Policies". The Oxford Handbook of Global Health Politics. doi:10.1093/oxfordhb/9780190456818.001.0001. ISBN   978-0-19-045681-8 . Retrieved 7 March 2021.
  6. ↑ Jennings, Michael (22 February 2021). "Vaccine diplomacy: how some countries are using COVID to enhance their soft power". The Conversation. Retrieved 7 March 2021.
  7. ↑ Hotez, Peter J. (26 June 2014). ""Vaccine Diplomacy": Historical Perspectives and Future Directions". PLOS Neglected Tropical Diseases. 8 (6): e2808. doi: 10.1371/journal.pntd.0002808 . ISSN   1935-2727. PMC   4072536 . PMID   24968231.
  8. ↑ Riedel, S. (2005). "Edward Jenner and the history of smallpox and vaccination". Proceedings (Baylor University. Medical Center). 18 (1): 21–25. doi:10.1080/08998280.2005.11928028. PMC   1200696 . PMID   16200144.
  9. ↑ "Vaccine Diplomacy". 2 May 2024.
  10. ↑ "PM backtracks on 'mandatory' vaccine". www.ntnews.com.au. 20 August 2020. Retrieved 21 August 2020.
  11. 1 2 Zhao, Suisheng (2023). The dragon roars back: transformational leaders and dynamics of Chinese foreign policy. Stanford, California: Stanford University Press. p. 90. ISBN   978-1-5036-3088-8. OCLC   1331741429.
  12. ↑ Cheng, Wenting (2023). China in Global Governance of Intellectual Property: Implications for Global Distributive Justice. Palgrave Socio-Legal Studies series. Palgrave Macmillan. ISBN   978-3-031-24369-1.
  13. ↑ Lin, Bonny; Funaiole, Matthew P.; Hart, Brian; Price, Hannah (September 30, 2021). "China Is Exploiting the Pandemic to Advance Its Interests, with Mixed Results".{{cite journal}}: Cite journal requires |journal= (help)
  14. ↑ Wheaton, Sarah (May 18, 2020). "Chinese vaccine would be 'global public good,' Xi says". Politico. Retrieved April 30, 2024.
  15. ↑ Liu R (31 December 2020). "China gives its first COVID-19 vaccine approval to Sinopharm". Reuters. Retrieved 31 December 2020.
  16. ↑ Turak, Natasha (18 January 2021). "The UAE is on track to have half its population vaccinated by the end of March". CNBC. Retrieved 21 January 2021.
  17. ↑ Dawn.com (2 February 2021). "PM Imran kicks off Pakistan's Covid-19 vaccination drive". DAWN.COM. Retrieved 3 February 2021.
  18. ↑ "Sisi says Egypt to begin COVID-19 vaccinations on Sunday". Reuters . 24 January 2021. Retrieved 24 January 2021.
  19. ↑ Dumpis, Toms (27 January 2021). "Morocco Receives Half a Million Doses of Chinese Sinopharm Vaccine". Morocco World News. Retrieved 28 January 2021.
  20. ↑ "Zimbabwe starts administering China's Sinopharm vaccines". thestar.com. 18 February 2021. Retrieved 20 February 2021.
  21. ↑ "Argentina autoriza la vacuna china Sinopharm para mayores de 60 años". El Comercio. Retrieved 26 March 2021.
  22. ↑ Aquino, Marco (10 February 2021). "'The best shield': Peru launches inoculation drive with Sinopharm vaccine". Reuters. Retrieved 10 February 2021.
  23. ↑ "Bolivia begins inoculation with Sinopharm jabs | The Star". www.thestar.com.my. Retrieved 28 February 2021.
  24. ↑ "Serbia Becomes First European Nation To Use China's Sinopharm Vaccine". Radio Free Europe/Radio Liberty. 20 January 2021. Retrieved 21 January 2021.
  25. ↑ "Hungary first EU nation to use China's Sinopharm vaccine against COVID". euronews. 24 February 2021. Retrieved 26 February 2021.
  26. ↑ "Belarus begins COVID-19 vaccinations with Chinese shots". eng.belta.by. 15 March 2021. Retrieved 16 March 2021.
  27. ↑ Graff, Peter (June 2, 2021). "Sinopharm can provide more than 1 bln COVID-19 shots beyond China in second half of year". Reuters.
  28. ↑ "WHO approves Sinopharm vaccine in potential boost to COVAX pipeline". Reuters. 7 May 2021. Retrieved 14 May 2021.
  29. ↑ Tarigan, Edna; Milko, Victoria (13 January 2021). "Indonesia starts mass COVID vaccinations over vast territory". Associated Press . Retrieved 15 January 2021.
  30. ↑ "Thailand Kicks Off Covid-19 Vaccine Program With Sinovac Shots". Bloomberg.com. Retrieved 28 February 2021.
  31. ↑ "China approves Sinovac vaccines for general public use". South China Morning Post. 6 February 2021. Retrieved 6 February 2021.
  32. ↑ Rochabrun, Marcelo. "Brazil health ministry says plans to order 30 million more Coronavac doses | The Chronicle Herald". www.thechronicleherald.ca. Retrieved 26 February 2021.
  33. ↑ Miranda, Natalia A. Ramos (28 January 2021). "Chile receives two million-dose first delivery of Sinovac COVID-19 vaccine". Reuters. Retrieved 30 January 2021.
  34. ↑ "BNamericas - Uruguay prepares to launch COVID-19 vaccinat..." BNamericas.com. Retrieved 1 March 2021.
  35. ↑ "Venustiano Carranza next up for Covid vaccination in Mexico City". Mexico News Daily. 15 March 2021. Retrieved 16 March 2021.
  36. ↑ "Anticovid vaccines run out as Dominican Republic awaits arrival of more doses". Dominican Today. Retrieved 10 March 2021.
  37. ↑ "Llegan a El Salvador un millón de dosis de la vacuna china CoronaVac contra el covid-19 de la farmacéutica Sinovac". Noticias de El Salvador - La Prensa Gráfica | Informate con la verdad (in European Spanish). Retrieved 28 March 2021.
  38. ↑ "Turkey aims to vaccinate 60 percent of population: Minister – Turkey News". Hürriyet Daily News. 11 February 2021. Retrieved 12 February 2021.
  39. ↑ "Vaccination with CoronaVac launched in Ukraine on April 13 – Health minister". www.unian.info. Retrieved 15 April 2021.
  40. ↑ Semini, Llazar. "Albania starts mass COVID vaccinations before tourist season". ABC News. Retrieved 28 March 2021.
  41. ↑ Liu, Roxanne (2 April 2021). "China Sinovac says it reached two billion doses annual capacity for COVID-19 vaccine". Reuters. Retrieved 2 April 2021.
  42. 1 2 Nebehay, Stephanie (1 June 2021). "WHO approves Sinovac COVID vaccine, the second Chinese-made dose listed". Reuters. Geneva. Retrieved 1 June 2021.
  43. ↑ Liu, Roxanne (25 February 2021). "China approves two more domestic COVID-19 vaccines for public use". Reuters. Retrieved 26 February 2021.
  44. ↑ "Pakistan purchases over 30 million COVID doses from China: sources". Ary News. 25 April 2021. Retrieved 26 April 2021.
  45. ↑ "Malaysia to receive CanSino vaccine this month | The Malaysian Insight". www.themalaysianinsight.com. Retrieved 3 April 2021.
  46. ↑ Ashok, Rashmi (22 March 2021). "UPDATE 2-China's CanSino Biologics COVID-19 vaccine receives emergency use approval in Hungary". Reuters. Retrieved 22 March 2021.
  47. ↑ "Membrii NITAG au venit cu recomandări privind utilizarea vaccinurilor împotriva COVID-19 în Republica Moldova". Ministerul Sănătății, Muncii și Protecţiei Sociale. 3 March 2021. Retrieved 21 May 2021.
  48. ↑ "'Our gratitude always': From China's CanSino, Mexico welcomes biggest vaccine shipment yet". Reuters. 11 February 2021. Retrieved 11 February 2021.
  49. ↑ "Argentina issues emergency approval to China's single-dose Cansino COVID-19 vaccine". Reuters. 11 June 2021. Retrieved 11 June 2021.
  50. ↑ "ISP Approves Emergency Use And Importation Of Cansino Vaccine To Fight COVID-19". Institute of Public Health of Chile. Retrieved 8 April 2021.
  51. ↑ "China can hit 500-mln-dose annual capacity of CanSinoBIO COVID-19 vaccine this year". finance.yahoo.com. 27 February 2021. Retrieved 28 February 2021.
  52. ↑ Yuliya Talmazan; Keir Simmons; Laura Saravia (18 May 2020). "China's Xi announces $2B for coronavirus response as WHO faces calls for investigation". NBC News. Archived from the original on 18 May 2020. Retrieved 18 May 2020.
  53. ↑ Ore, Diego (23 July 2020). "Mexico says China plans $1 billion loan to ease Latam access to virus vaccine". Reuters. Retrieved 16 August 2020.
  54. ↑ "China promises Mekong neighbours access to Chinese Covid-19 vaccine". South China Morning Post. 24 August 2020. Retrieved 24 August 2020.
  55. ↑ "WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations". World Health Organization (WHO) (Press release). Retrieved 1 June 2021.
  56. ↑ "Chinese drugmakers agree to supply more than half a billion vaccines to COVAX". Reuters. 2021-07-12. Retrieved 2021-07-13.
  57. ↑ "China's Clover to supply up to 414 mln COVID-19 doses to COVAX scheme". Reuters. 2021-06-30. Retrieved 2021-07-13.
  58. ↑ Wong, Brian. "China's Mask Diplomacy". thediplomat.com. Retrieved 2022-01-15.
  59. ↑ "China Covid-19: How state media and censorship took on coronavirus". BBC News. 2020-12-29. Retrieved 2022-01-15.
  60. ↑ Lee, Seow Ting (March 2023). "Vaccine diplomacy: nation branding and China's COVID-19 soft power play". Place Branding and Public Diplomacy. 19 (1): 64–78. doi:10.1057/s41254-021-00224-4. ISSN   1751-8040. PMC   8259554 .
  61. ↑ Huang, Laura Silver, Kat Devlin and Christine (2020-10-06). "Unfavorable Views of China Reach Historic Highs in Many Countries". Pew Research Center. Retrieved 2024-05-01.{{cite web}}: CS1 maint: multiple names: authors list (link)
  62. ↑ McCarthy, Niall. "America First? Covid-19 Vaccine Production & Exports [Infographic]". Forbes. Retrieved 4 April 2021.
  63. ↑ "Covid vaccine: Why India's second wave has sparked global concerns". The Times of India. 4 April 2021. Retrieved 2 May 2021.
  64. ↑ "India is giving away millions of coronavirus vaccine doses as a tool of diplomacy". The Washington Post .
  65. ↑ Roy, Shubhajit (2021-03-10). "India to supply Covid vaccines to Pakistan". The Indian Express. Retrieved 2021-07-31.
  66. ↑ "Has India's Vaccine Diplomacy Fallen Flat As Domestic Covid-19 Cases Surge & Global Media Lambasts The Govt?". Latest Asian, Middle-East, EurAsian, Indian News. 28 April 2021. Retrieved 2 May 2021.
  67. ↑ Haidar, Suhasini (29 April 2021). "India unlikely to resume 'Vaccine Maitri' for neighbours before July". The Hindu. ISSN   0971-751X . Retrieved 2 May 2021.
  68. ↑ "MEA Vaccine supply". MEA. 29 May 2021. Retrieved 9 September 2021.
  69. ↑ Arora, Neha; Das, Krishna N. (2021-09-20). "India to restart COVID vaccine exports to COVAX, neighbours". Reuters. Retrieved 2021-09-26.
  70. 1 2 "Mexico to trial China, U.S. COVID-19 vaccines, may produce some". Reuters. 12 August 2020. Retrieved 21 August 2020.
  71. 1 2 "Japan's 'medical diplomacy' in ASEAN aims to sap China clout". Nikkei Asian Review. 18 August 2020. Retrieved 21 August 2020.
  72. ↑ Grove, Thomas (11 August 2020). "Russia Registers World's First Covid-19 Vaccine Despite Safety Concerns". Wall Street Journal. ISSN   0099-9660 . Retrieved 21 August 2020.
  73. ↑ "Azerbaijan Gets First Batch of Covid-19 Vaccine Directly from China". caspiannews.com. Retrieved 12 June 2021.
  74. ↑ "Turkey donates COVID-19 vaccines to North Macedonia". Daily Sabah. 9 June 2021. Retrieved 12 June 2021.
  75. ↑ "AstraZeneca receives $1 billion in U.S. Funding for Oxford University coronavirus vaccine". CNBC . 21 May 2020.
  76. ↑ Hopkins, Jared S. (12 August 2020). "Moderna Inks $1.5 Billion Coronavirus Vaccine Deal With U.S." Wall Street Journal. ISSN   0099-9660 . Retrieved 21 August 2020.
  77. ↑ Tony Walker, The Conversation (15 March 2021). "The Quad has made a good start with vaccine diplomacy. Now it should avoid the 'China Trap'". Scroll.in. Retrieved 15 March 2021.
  78. ↑ Massie, Graeme (25 April 2021). "'Vaccine apartheid': US under fire for sitting on stockpile while developing nations face deadly shortage". The Independent. Retrieved 3 May 2021.
  79. ↑ Landler, Mark (4 February 2021). "Johnson Wins Vaccine Spat With E.U., but a Struggle Over Northern Ireland Looms". The New York Times. ISSN   0362-4331 . Retrieved 7 March 2021.
  80. ↑ "EU vaccine export curbs spark dispute among member states". www.ft.com. 24 March 2021. Retrieved 5 April 2021.
  81. ↑ Lagman, J. D. (2021). "Vaccine nationalism: A predicament in ending the COVID-19 pandemic". Journal of Public Health (Oxford, England). 43 (2): e375–e376. doi: 10.1093/pubmed/fdab088 . PMC   7989352 . PMID   33730161.
  82. ↑ Ramgopal, Kit; Romo, Christine; McFadden, Cynthia (23 January 2021). "How 'vaccine nationalism' could prolong the Covid-19 pandemic". NBC News.
  83. ↑ Talwani, Hardi (23 August 2020). "Vaccine Nationalism: The Ethical Conundrum in the age of Global Pandemic". Global Views 360. Archived from the original on 30 June 2022. Retrieved 20 September 2020.
  84. ↑ Ghebreysus, T. Vaccine Nationalism harms everyone and protects no one. Foreign Policy. 2 February 2021.
  85. ↑ Kupferschmidt, Kai (2020-07-28). "'Vaccine nationalism' threatens global plan to distribute COVID-19 shots fairly". Science. doi:10.1126/science.abe0601. ISSN   0036-8075. S2CID   225369189.
  86. ↑ Wagner, Caroline E.; Saad-Roy, Chadi M.; Morris, Sinead E.; Baker, Rachel E.; Mina, Michael J.; Farrar, Jeremy; Holmes, Edward C.; Pybus, Oliver G.; Graham, Andrea L.; Emanuel, Ezekiel J.; Levin, Simon A. (2021). "Vaccine nationalism and the dynamics and control of SARS-CoV-2". Science. 373 (6562): eabj7364. doi: 10.1126/science.abj7364 . PMC   9835930 . PMID   34404735. S2CID   237199024.
  87. ↑ Hishammuddin Hussein [@HishammuddinH2O] (August 6, 2020). "Spoke on the phone yesterday with HE Wang Yi, China's Foreign Minister – both countries must actively carry out #COVID19 vaccine cooperation, and explore ways to jointly ensure supply chain security to send a positive signal of unity and cooperation between Malaysia & China" (Tweet). Retrieved 21 August 2020– via Twitter.
  88. ↑ Hishammuddin Hussein [@HishammuddinH2O] (August 6, 2020). "Just spoke on the phone with U.S. Secretary of State @SecPompeo – both agreed to focus efforts on the manufacturing & distribution of the #COVID19 vaccine, once it is readily available. Also discussed regarding the #SouthChinaSea which must remain a sea of peace and trade" (Tweet). Retrieved 21 August 2020– via Twitter.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.